Two-thirds of the population of India have antibodies against the coronavirus, according to data from a national seroprevalence survey conducted in 70 districts of the country, informs Hindustan Times.
The survey, carried out in June and July, revealed that the 67,6 % of the country’s inhabitants had already developed antibodies against SARS-CoV-2.
The age distribution of seroprevalence showed that children between 6 and 9 years old are the least protected against the coronavirus, having developed antibodies the 57,2 %; while the seroprevalence in the group between 45 and 60 years is 77.6%. At least 61.6% of adolescents between the ages of 10 and 17 had antibodies against COVID-19, a similar percentage to 66.7% of people between 18 and 44 years old.
Overall seroprevalence is 67.6% in the entire population. In people of 6-9 years age group, it was 57.2%; in 10-17 years, it was 61.6%; in 18-44 years, it was 66.7%; in 45-60 years, it was 77.6%: ICMR DG Dr Balram Bhargava pic.twitter.com/rUFlW78MNG
“We must maintain the appropriate behavior for the covid, as well as the participation of the community”, he pointed Balram Bhargava, director general of the Indian Council of Medical Research, while admitting that the data obtained represents a ray of hope.
In parallel, it has been revealed that the highest seroprevalence corresponds to vaccinated people (89.8%), compared to those that have not been inoculated (62.3%). Also, 81% of people who have only received the first dose of the vaccine developed antibodies against the disease.
India has reported 30,093 cases of Covid-19 in the last 24 hours, the lowest number in 4 months.